Table 1.
General Demographic Parameters
| Characteristic | Frequency, Value, or IQR |
|---|---|
| Subjects | n=60 |
| Age, mean±SD | 60.4±7.2 |
| Men (%) | 36 (60%) |
| Ethnicity | |
| White | 55 (91.7%) |
| African American | 5 (8.3%) |
| Risk factors | |
| Hypertension | 50 (83.3%) |
| Dyslipidemia | 58 (96.7%) |
| Tobacco use (former or current) | 35 (58.3%)) |
| Diabetes mellitus | 44 (73.3%) |
| Framingham Risk Score (10‐year risk; mean±SD) | 8.2±6.1 |
| Symptoms | |
| Chest pain (angina) | 27 (45%) |
| Shortness of breath | 16 (26.7%) |
| Medications | |
| Aspirin | 43 (71.7%) |
| Beta‐blocker | 30 (50%) |
| Angiotensin‐converting enzyme inhibitor | 18 (30%) |
| Angiotensin receptor blocker | 6 (10%) |
| Nitrate | 6 (10%) |
| Statin | 40 (66.7%) |
| Cholesterol absorption inhibitor | 15 (25%) |
| Niacin | 9 (15%) |
| Fibric acid derivative | 3 (5%) |
| Laboratory values | |
| Total cholesterol, mg/dL | 154.6±47.9 (124 to 172) |
| ApoB, mg/dL | 78.4±29.8 (59.7 to 91.5) |
| LDL cholesterol, mg/dL | 87.5±37.4 (59.2 to 107.1) |
| sd‐LDL‐C, mg/dL | 14.8±10.8 (6.8 to 18.6) |
| ApoAI, mg/dL | 141.3±31.6 (126.3 to 154.3) |
| HDL cholesterol, mg/dL | 37.7±10.9 (30.7 to 41.9) |
| Triglycerides, mg/dL | 127.3±60.9 (79.7 to 164) |
HDL indicates high‐density lipoprotein; IQR, interquartile range; LDL, low‐density lipoprotein; SD, standard deviation; sd‐LDL, small, dense low‐density lipoprotein.